Skip to main content

Table 4 FIQL domain scores by visit and pre–post differences (all patients, ITT)

From: Skeletal muscle-derived cell implantation for the treatment of sphincter-related faecal incontinence

 

V-2

V0

V2

V3

V4

By visit, mean (SD)

 Lifestyle

2.1 (0.71)

2.2 (0.72)

3.2 (0.77)

3.3 (0.69)

3.4 (0.77)

 Coping/behaviour

1.4 (0.34)

1.6 (0.54)

2.7 (0.77)

2.8 (0.86)

3.0 (0.91)

 Depression/perception

2.3 (0.84)

2.2 (0.75)

3.2 (0.72)

3.3 (0.73)

3.3 (0.72)

 Embarrassment

1.4 (0.58)

1.7 (0.66)

2.8 (0.89)

3.0 (0.80)

3.2 (0.84)

   

V2 – V0

V3 – V0

V4– V0

Pre–post differences, mean (95% CI)

 Lifestyle

  

1.0 (0.74; 1.19)*

1.1 (0.92; 1.35)*

1.2 (0.95; 1.46)*

 Coping/behaviour

  

1.1 (0.83; 1.35)*

1.3 (0.98; 1.55)*

1.4 (1.07; 1.67)*

 Depression/perception

  

0.9 (0.68; 1.14)*

1.0 (0.77; 1.26)*

1.1 (0.81; 1.33)*

 Embarrassment

  

1.0 (0.66; 1.29)*

1.2 (0.92; 1.52)*

1.4 (1.11; 1.73)*

  1. FIQL Fecal Incontinence Quality of Life, ITT intention to treat, V visit, V-2 3 months pre implantation, V0 implantation, V2, V3 and V4 1, 6 and 12 months post implantation, SD standard deviation, CI confidence interval
  2. *Significant change from baseline according to 95% CI
Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512